These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34608880)

  • 21. Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis.
    Uflacker R
    Tech Vasc Interv Radiol; 2003 Mar; 6(1):59-69. PubMed ID: 12772131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Trans-jugular intrahepatic portosystemic stent-shunt (TIPS) in a patient with Budd-Chiari syndrome].
    Walter E; Muntwyler J; Bertschinger P; Flury R; Ochs A; Haag K; Rössle M; Blum HE
    Schweiz Med Wochenschr; 1993 Sep; 123(36):1696-702. PubMed ID: 8211021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis.
    Rodrigues SG; Sixt S; Abraldes JG; De Gottardi A; Klinger C; Bosch J; Baumgartner I; Berzigotti A
    Aliment Pharmacol Ther; 2019 Jan; 49(1):20-30. PubMed ID: 30450634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transjugular Intrahepatic Portosystemic Shunt Placement During Pregnancy: A Case Series of Five Patients.
    Ingraham CR; Padia SA; Johnson GE; Easterling TR; Liou IW; Kanal KM; Valji K
    Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1205-10. PubMed ID: 25613670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
    Opitz T; Buchwald AB; Lorf T; Awuah D; Ramadori G; Nolte W
    Z Gastroenterol; 2003 May; 41(5):413-8. PubMed ID: 12772054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the necessity of anticoagulation therapy and influencing factors of stent occlusion after transjugular intrahepatic portosystemic shunt].
    Xia YF; Song AC; Wang AJ; Huang CQ; Zhang C
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):728-734. PubMed ID: 36038342
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.
    Schultheiss M; Bettinger D; Sturm L; Schmidt A; Backhus J; Waidmann O; Radecke K; Grandt D; Thimme R; Rössle M
    Cardiovasc Intervent Radiol; 2022 May; 45(5):542-549. PubMed ID: 35020042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budd-Chiari syndrome and acute portal vein thrombosis: management by a transjugular intrahepatic portosystemic shunt (TIPS) and portal vein interventions via a TIPS.
    Kori I; Bar-Zohar D; Carmiel-Haggai M; Samuels D; Nakache R; Oren R; Kessler A; Szold O; Ben-Haim M
    J Gastrointest Surg; 2006 Mar; 10(3):417-21. PubMed ID: 16504889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms.
    Shyu M; Winters A; Naymagon L; Patel R; Schiano TD; Tremblay D
    Thromb Res; 2024 Feb; 234():32-35. PubMed ID: 38154200
    [No Abstract]   [Full Text] [Related]  

  • 31. Utility of Transjugular Intrahepatic Portosystemic Shunt Placement for Maintaining Portal Vein Patency in Candidates on Wait Lists Who Develop Thrombus.
    Alani M; Rowley M; Kang P; Chen S; Hirsch K; Seetharam A
    Exp Clin Transplant; 2020 Dec; 18(7):808-813. PubMed ID: 31830878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.
    Hung ML; Lee EW
    Clin Liver Dis; 2019 Nov; 23(4):737-754. PubMed ID: 31563220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes.
    Vizzutti F; Schepis F; Arena U; Fanelli F; Gitto S; Aspite S; Turco L; Dragoni G; Laffi G; Marra F
    Intern Emerg Med; 2020 Jan; 15(1):37-48. PubMed ID: 31919780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular intrahepatic portosystemic shunt as a bridge to non-hepatic surgery in cirrhotic patients with severe portal hypertension: a systematic review.
    Lahat E; Lim C; Bhangui P; Fuentes L; Osseis M; Moussallem T; Salloum C; Azoulay D
    HPB (Oxford); 2018 Feb; 20(2):101-109. PubMed ID: 29110990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience.
    Buechter M; Manka P; Gerken G; Canbay A; Blomeyer S; Wetter A; Altenbernd J; Kahraman A; Theysohn JM
    Dig Dis; 2018; 36(3):218-227. PubMed ID: 29316565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
    Wu W; Zhang H; Zeng Z; Wang X; Kong D
    Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational hemodynamic analysis for optimal stent position in the transjugular intrahepatic portosystemic shunt procedure.
    Yin K; Wang X; Zheng T
    J Biomech; 2022 Oct; 143():111303. PubMed ID: 36126502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.